Skip to main content

Advertisement

Log in

Expression of Peroxiredoxin 1, 2, 3, and 6 Genes in Cancer Cells during Drug Resistance Formation

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied the expression of peroxiredoxin genes (PRDX1, PRDX2, PRDX3, and PRDX6) in human erythroleukemia K652, human breast carcinoma MCF-7, and human ovarian carcinoma SKOV-3 cells during cisplatin resistance development. It was found that drug resistance formation was accompanied by a significant increase in the expression of PRDX1, PRDX2, PRDX3, PRDX6 genes in all cancer cell strains, which confirms the important contribution of redox-dependent mechanisms into the development of cisplatin resistance of cancer cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. E. B. Men’shikova, V. Z. Lankin, and N. K. Zenkov, et al., Oxidative Stress. Prooxidants and Antioxidants [in Russian], Moscow (2006).

  2. T. M. Shuvaeva, V. I. Novoselov, E. E. Fesenko, and V. M. Lipkin, Bioorgan. Khimiya, 35, 581-596 (2009).

    CAS  Google Scholar 

  3. A. B. Fisher, Antioxid. Redox. Signal., 15, No. 3, 831-844 (2011).

    Article  PubMed  CAS  Google Scholar 

  4. B. Hofmann, H. J. Hecht, and L. Flohe, Biol. Chem., 383, No. 3-4, 347-364 (2002).

    PubMed  CAS  Google Scholar 

  5. T. Ishii, K. Itoh, E. Ruiz, et al., Circ. Res., 94, No. 5, 609-616 (2004).

    Article  PubMed  CAS  Google Scholar 

  6. R. Kachadourian, H. M. Leitner, and B. J. Day, Int. J. Oncol, 31, No. 1, 161-168 (2007).

    PubMed  CAS  Google Scholar 

  7. H. Kim, T. H. Lee, E. S. Park, et al., J. Biol. Chem., 275, No. 24, 18,266-18,270 (2000).

    CAS  Google Scholar 

  8. Y. Manevich and A. B. Fisher, Free Radic. Biol. Med., 38, No. 11, 1422-1432 (2005).

    Article  PubMed  CAS  Google Scholar 

  9. A. Miyajima, J. Nakashima, K. Yoshioka, et al., Br. J. Cancer, 76, No. 2, 206-210 (1997).

    Article  PubMed  CAS  Google Scholar 

  10. D. Y. Noh, S. J. Ahn, R. A. Lee, et al., Anticancer Res., 21, No. 313, 2085-2090 (2001).

    PubMed  CAS  Google Scholar 

  11. J. H. Pak, W. H. Choi, H. M. Lee, et al., Cancer Invest. 29, No. 1, 21-28 (2011).

    Article  PubMed  CAS  Google Scholar 

  12. S. G. Rhee and H. A. Woo, Antioxid. Redox. Signal., 15, No. 3, 781-794 (2011).

    Article  PubMed  CAS  Google Scholar 

  13. I. S. Song, H. K. Kim, S. H. Jeong, et al., Int. J. Mol. Sci., 12, No. 10, 7163-7185 (2011).

    Article  PubMed  CAS  Google Scholar 

  14. G. Wang, E. Reed, and Q. Q. Li, Oncol. Rep., 12, No. 5, 955-965 (2004).

    PubMed  CAS  Google Scholar 

  15. Z. A.Wood, L. B. Poole, and P. A. Karplus, Science, 300, 650-653 (2003).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. V. Kalinina.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 153, No. 6, pp. 861-864, June, 2012

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalinina, E.V., Berezov, T.T., Shtil’, A.A. et al. Expression of Peroxiredoxin 1, 2, 3, and 6 Genes in Cancer Cells during Drug Resistance Formation. Bull Exp Biol Med 153, 879–882 (2012). https://doi.org/10.1007/s10517-012-1849-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-012-1849-7

Key Words

Navigation